Literature DB >> 29090735

Learning from the Law. A review of 21 years of litigation for pain during caesarean section.

K McCombe1,2, D G Bogod3.   

Abstract

The large majority of caesarean sections in the UK are now carried out under neuraxial anaesthesia. Although this technique is widely accepted as being the safest option in most circumstances, the use of regional anaesthesia increases the risk of patients experiencing intra-operative discomfort or pain. Pain during operative obstetric delivery is the commonest successful negligence claim relating to regional anaesthesia against obstetric anaesthetists in the UK. In the following article, using a database of over 360 cases spanning 21 years, we break down and examine the recurrent components of medicolegal claims concerning pain during caesarean section and consider how anaesthetists might avoid litigation.
© 2017 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Keywords:  ethics principles: autonomy; pregnancy

Mesh:

Year:  2017        PMID: 29090735     DOI: 10.1111/anae.14119

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

1.  Reports in anaesthesia come of age!

Authors:  S Dalay; R J Daly Guris; C L Shelton; M Charlesworth
Journal:  Anaesth Rep       Date:  2019-07-29

Review 2.  The Current Role of General Anesthesia for Cesarean Delivery.

Authors:  Laurence Ring; Ruth Landau; Carlos Delgado
Journal:  Curr Anesthesiol Rep       Date:  2021-02-24

3.  Troubleshooting obstetric spinal anaesthesia at district hospital level.

Authors:  David G Bishop; Simon P D P Le Roux
Journal:  S Afr Fam Pract (2004)       Date:  2022-07-28

4.  Prevention and management of intra-operative pain during caesarean section under neuraxial anaesthesia: a technical and interpersonal approach.

Authors:  F Plaat; S E R Stanford; D N Lucas; J Andrade; J Careless; R Russell; D Bishop; Q Lo; D Bogod
Journal:  Anaesthesia       Date:  2022-03-24       Impact factor: 12.893

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.